Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 717 
This article has been cited by
1Study of the effect of combined interferon and ribavirin therapy on the hearing profile of hepatitis C virus patients
Samir Asal,Ossama Sobhy,Omneya Ismail,Essam Bedewy
The Egyptian Journal of Otolaryngology.2015;31(4)237
[DOI]
2Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection
Hsin-Chien Chen,Chi-Hsiang Chung,Chih-Hung Wang,Jung-Chun Lin,Wei-Kuo Chang,Fu-Huang Lin,Chang-Huei Tsao,Yung-Fu Wu,Wu-Chien Chien,Yury E. Khudyakov
PLOS ONE.2017;12(4)e0175266
[DOI]
3Distortion-Product Otoacoustic Emissions: A Useful Test for Monitoring Ototoxicity Induced by Pegylated Interferon and Ribavirin Treatment in Patients with Chronic Hepatitis C
M. Casale,C. Mazzarelli,U. Vespasiani Gentilucci,M. Potena,M. Pappacena,F. Faiella,G. Galati,F. Salvinelli,A. Picardi
International Journal of Immunopathology and Pharmacology.2012;25(2)551
[DOI]
4Assessment of auditory function in hepatitis C patients managed by combination of sofosbuvir and daclatsavir
El-Zahraa M. Meghezel,Mohammed A. Abd Al-Ghaffar,Asmaa Naser Mohammad,Samar M. Mahmoud,Usama M. Abdelaal,Salwa Mourad
The Egyptian Journal of Otolaryngology.2022;38(1)551
[DOI]
  Search 
  The Journal 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit Articles

Alerts

Join us